Citigroup’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $531M | Buy |
577,200
+214,200
| +59% | +$217M | 0.23% | 82 |
|
|
2025
Q4 | $390M | Buy |
363,000
+13,700
| +4% | +$13.1M | 0.17% | 93 |
|
|
2025
Q3 | $267M | Buy |
349,300
+32,600
| +10% | +$24.3M | 0.12% | 162 |
|
|
2025
Q2 | $247M | Buy |
316,700
+57,700
| +22% | +$44.8M | 0.12% | 168 |
|
|
2025
Q1 | $214M | Buy |
259,000
+40,000
| +18% | +$33.3M | 0.11% | 172 |
|
|
2024
Q4 | $169M | Sell |
219,000
-8,700
| -4% | -$7.2M | 0.1% | 184 |
|
|
2024
Q3 | $202M | Buy |
227,700
+59,800
| +36% | +$53.8M | 0.12% | 154 |
|
|
2024
Q2 | $152M | Sell |
167,900
-35,900
| -18% | -$28.7M | 0.1% | 188 |
|
|
2024
Q1 | $159M | Sell |
203,800
-38,800
| -16% | -$27.6M | 0.1% | 184 |
|
|
2023
Q4 | $141M | Buy |
242,600
+48,500
| +25% | +$28.3M | 0.1% | 179 |
|
|
2023
Q3 | $104M | Sell |
194,100
-40,300
| -17% | -$20.8M | 0.08% | 223 |
|
|
2023
Q2 | $110M | Buy |
234,400
+58,200
| +33% | +$24.4M | 0.07% | 209 |
|
|
2023
Q1 | $60.5M | Sell |
176,200
-69,900
| -28% | -$23.6M | 0.04% | 347 |
|
|
2022
Q4 | $90M | Buy |
246,100
+30,300
| +14% | +$10.7M | 0.07% | 250 |
|
|
2022
Q3 | $69.8M | Buy |
215,800
+91,800
| +74% | +$29.1M | 0.05% | 292 |
|
|
2022
Q2 | $40.2M | Buy |
124,000
+51,300
| +71% | +$15.4M | 0.03% | 463 |
|
|
2022
Q1 | $20.8M | Sell |
72,700
-64,300
| -47% | -$16.5M | 0.01% | 926 |
|
|
2021
Q4 | $37.8M | Buy |
137,000
+12,400
| +10% | +$3.14M | 0.02% | 687 |
|
|
2021
Q3 | $28.8M | Buy |
124,600
+25,800
| +26% | +$6.37M | 0.02% | 791 |
|
|
2021
Q2 | $22.7M | Buy |
98,800
+22,100
| +29% | +$4.44M | 0.01% | 928 |
|
|
2021
Q1 | $14.3M | Sell |
76,700
-152,400
| -67% | -$29.8M | 0.01% | 1148 |
|
|
2020
Q4 | $38.7M | Buy |
229,100
+45,000
| +24% | +$6.72M | 0.02% | 677 |
|
|
2020
Q3 | $27.3M | Buy |
184,100
+56,500
| +44% | +$8.74M | 0.02% | 758 |
|
|
2020
Q2 | $20.9M | Sell |
127,600
-67,800
| -35% | -$10.4M | 0.02% | 795 |
|
|
2020
Q1 | $27.1M | Buy |
195,400
+54,500
| +39% | +$7.49M | 0.02% | 585 |
|
|
2019
Q4 | $18.5M | Buy |
140,900
+26,200
| +23% | +$3.04M | 0.01% | 1023 |
|
|
2019
Q3 | $12.8M | Sell |
114,700
-53,800
| -32% | -$5.99M | 0.01% | 1216 |
|
|
2019
Q2 | $18.7M | Sell |
168,500
-162,900
| -49% | -$19.2M | 0.02% | 970 |
|
|
2019
Q1 | $43M | Buy |
331,400
+91,100
| +38% | +$11.1M | 0.04% | 449 |
|
|
2018
Q4 | $27.8M | Sell |
240,300
-8,500
| -3% | -$950K | 0.03% | 643 |
|
|
2018
Q3 | $26.7M | Buy |
248,800
+121,700
| +96% | +$12.2M | 0.02% | 675 |
|
|
2018
Q2 | $10.8M | Sell |
127,100
-74,900
| -37% | -$6.15M | 0.01% | 1220 |
|
|
2018
Q1 | $15.6M | Sell |
202,000
-12,500
| -6% | -$1.01M | 0.01% | 941 |
|
|
2017
Q4 | $18.1M | Buy |
214,500
+61,200
| +40% | +$5.21M | 0.01% | 893 |
|
|
2017
Q3 | $13.1M | Buy |
153,300
+20,200
| +15% | +$1.66M | 0.01% | 1052 |
|
|
2017
Q2 | $11M | Sell |
133,100
-74,600
| -36% | -$6.09M | 0.01% | 1086 |
|
|
2017
Q1 | $17.5M | Sell |
207,700
-64,700
| -24% | -$5.18M | 0.02% | 809 |
|
|
2016
Q4 | $20M | Sell |
272,400
-183,600
| -40% | -$13.7M | 0.02% | 777 |
|
|
2016
Q3 | $36.6M | Sell |
456,000
-140,200
| -24% | -$11.2M | 0.03% | 446 |
|
|
2016
Q2 | $47M | Buy |
596,200
+405,100
| +212% | +$30.5M | 0.05% | 340 |
|
|
2016
Q1 | $13.8M | Sell |
191,100
-193,500
| -50% | -$14.6M | 0.02% | 798 |
|
|
2015
Q4 | $32.4M | Sell |
384,600
-98,900
| -20% | -$8.21M | 0.03% | 515 |
|
|
2015
Q3 | $40.5M | Buy |
483,500
+138,400
| +40% | +$11.7M | 0.04% | 405 |
|
|
2015
Q2 | $28.8M | Buy |
345,100
+68,300
| +25% | +$5.2M | 0.03% | 608 |
|
|
2015
Q1 | $20.1M | Sell |
276,800
-1,145,400
| -81% | -$81.5M | 0.02% | 764 |
|
|
2014
Q4 | $98.1M | Buy |
1,422,200
+329,500
| +30% | +$22.2M | 0.09% | 219 |
|
|
2014
Q3 | $70.9M | Sell |
1,092,700
-1,029,200
| -49% | -$65.2M | 0.06% | 284 |
|
|
2014
Q2 | $132M | Buy |
2,121,900
+269,200
| +15% | +$16.1M | 0.13% | 143 |
|
|
2014
Q1 | $109M | Buy |
1,852,700
+1,262,000
| +214% | +$70.4M | 0.11% | 139 |
|
|
2013
Q4 | $30.1M | Buy |
590,700
+199,200
| +51% | +$9.98M | 0.03% | 569 |
|
|
2013
Q3 | $19.7M | Buy |
391,500
+35,600
| +10% | +$1.86M | 0.02% | 750 |
|
|
2013
Q2 | $17.5M | Buy |
+355,900
| New | +$19.4M | 0.02% | 740 |
|
Other funds holding LLY
VCM
VPM
Citigroup's LLY Position: Q1 2026 in Review
Citigroup increased its Eli Lilly (LLY) stake by 66% in Q1 2026, buying an estimated $438M and bringing the position to 1,091,983 shares worth $1B. The position accounts for 0.43% of the portfolio, ranked #39.
Citigroup first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Citigroup held 1,091,983 shares of Eli Lilly worth $1B as of Q1 2026.
- Citigroup bought 432,352 Eli Lilly shares in Q1 2026, an estimated $438M.
- Eli Lilly made up 0.43% of Citigroup's portfolio in Q1 2026, its #39 holding.
- Citigroup first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.